Search

Search Constraints

You searched for: Author/Creator Heilig, Christoph E.

Search Results

1. Analysis of mutational signatures with yet another package for signature analysis. Issue 5 (31st December 2020)

2. Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine. Issue 6 (9th August 2021)

3. Bcl‐xL as prognostic marker and potential therapeutic target in cholangiocarcinoma. (14th September 2022)

4. Gene expression-based prediction of pazopanib efficacy in sarcoma. (September 2022)

5. Germline SDHB‐inactivating mutation in gastric spindle cell sarcoma. Issue 10 (26th June 2020)

6. MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers. Issue 14 (13th June 2022)

8. Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL. Issue 1 (4th December 2020)

9. Variant classification in precision oncology. Issue 11 (21st May 2019)

10. Vorinostat in refractory soft tissue sarcomas – Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO). (September 2016)